Cai-Cun Zhou (Caicun Zhou)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Pseudomonas Aeruginosa

Top Venues

Journal for immunotherapy of cancer

Disease markers

Journal of hematology & oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Peixin Chen, Lishu Zhao, Hao Wang, Liping Zhang, Wei Zhang, Jun Zhu, Jia Yu, Sha Zhao, Wei Li, Chenglong Sun, Chunyan Wu, Yayi He, Cai-Cun Zhou
Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancer. Journal for immunotherapy of cancer 9 (8) (2022)
Minlin Jiang, Chunyan Wu, Liping Zhang, Chenglong Sun, Hao Wang, Yi Xu, Hui Sun, Jun Zhu, Wencheng Zhao, Qiyu Fang, Jia Yu, Peixin Chen, Shengyu Wu, Zixuan Zheng, Yayi He, Cai-Cun Zhou
FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III. Journal for immunotherapy of cancer 9 (5) (2022)
Yayi He, Xiaogang Liu, Hao Wang, Liang Wu, Minlin Jiang, Haoyue Guo, Junjie Zhu, Shengyu Wu, Hui Sun, Shanhao Chen, Yuming Zhu, Cai-Cun Zhou, Yang Yang
Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung Adenocarcinoma. Small methods 5 (6) (2021)
Jia-Wei Luo, Yan-Hua Guo, Feng-Ying Wu, Xue-Fei Li, Xue-Cheng Sun, Jia-Lu Wang, Cai-Cun Zhou
Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma. Disease markers 2021 (2021)
Peixin Chen, Liping Zhang, Wei Zhang, Chenglong Sun, Chunyan Wu, Yayi He, Cai-Cun Zhou
Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancer. Journal for immunotherapy of cancer 8 (2) (2021)
Minlin Jiang, Peixin Chen, Lei Wang, Wei Li, Bin Chen, Yu Liu, Hao Wang, Sha Zhao, Lingyun Ye, Yayi He, Cai-Cun Zhou
cGAS-STING, an important pathway in cancer immunotherapy. Journal of hematology & oncology 13 (1) (2020)